Press Releases

All Releases
View Summary Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017
Oct 16, 2017
PDF 332.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Leadership Change
Sep 6, 2017
PDF 281.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Aug 31, 2017
PDF 14.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Aug 21, 2017
PDF 334.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update
Aug 3, 2017
PDF 101.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call
Jul 20, 2017
PDF 12.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease
Jul 20, 2017
PDF 290.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Jun 8, 2017
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference
Jun 1, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
May 10, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide's Effect on Pain at Digestive Disease Week® 2017
May 9, 2017
PDF 337.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
May 8, 2017
PDF 99.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017
May 1, 2017
PDF 292.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
Apr 24, 2017
PDF 13.0 KB Add to Briefcase
View Summary Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
Apr 13, 2017
PDF 389.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer
Apr 6, 2017
PDF 16.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 10, 2017
PDF 12.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
Mar 9, 2017
PDF 77.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017
Feb 23, 2017
PDF 13.7 KB Add to Briefcase
Showing 1-20 of 244 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.